Effect of Phytochemical Compounds on Trichomonastenax, an Oral Protozoan. Trichomonastenax is an oral protozoan with an estimated global pooled prevalence of 17% in the human population.1 Observational studies have demonstrated a significant statistical correlation between oral colonization by T. tenax and the progression of periodontal disease.2 Proposed pathogenic mechanisms
Detection of trichomonads in patients with lung cancer and transcription analysis on the response of human pulmonary epithelial cells to Trichomonastenax invasion. Lung cancer is one of the most prevalent malignancies worldwide. Substantial research has illuminated the intricate interplay between microorganisms and human health, revealing their role in disease regulation. Trichomonads is a flagellated protozoan in the human cavity and have been previously identified as a pathogen associated with pneumonia, contributing to tissue chronic inflammation and carcinogenesis. Nested polymerase chain reaction methods were employed to scrutinize the prevalence of trichomonads in the bronchovesicular fluid of patients diagnosed with lung cancer. Subsequently, the influence of Trichomonastenax invasion
Observational cross-sectional study of Trichomonastenax in patients with periodontal disease attending a Chilean university dental clinic. The oral flagellated protozoan Trichomonastenax has been associated with patients with periodontal disease. However, no recent studies have been conducted on the prevalence of T. tenax in Chile. The aim of this study was to determine the presence of T
A false-positive Trichomonas vaginalis result due to Trichomonastenax presence in clinical specimens may reveal a possible Trichomonastenax urogenital infection.
The Relationship between Entamoeba gingivalis and Trichomonastenax with Periodontitis and Gingivitis: A systematic review and meta-analysis PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO
The Effect of Nonsurgical Periodontal Therapy on TrichomonasTenax and Entamoeba Gingivalis in Patients with Chronic Periodontitis Trichomonastenax and Entamoeba gingivalis are commensal protozoa which inhabit the human oral cavity. These parasites are found in patients with poor oral hygiene and might be a reason for progressive periodontal diseases. The aim of this study was to evaluate = 0.007) and plaque (p= 0.027) three weeks after the treatment. Likewise, the frequency of Trichomonastenax reduced in saliva (p= 0.030); however, the decrease was not significant in plaque (p= 0.913). Trichomonastenax frequency in dental plaque directly related to the severity of periodontitis (r= 0.565, p≤ 0.000). In contrast, the number of Entamoeba gingivalis in both saliva (r= -0.405, p≤ 0.005
Canine Trichomonastenax mandibular gland infestation Several species of trichomonads are intestinal or urogenital parasites of humans and animals, with only a few species typically being located in the oral cavity. The prevalence of oral trichomoniasis in dogs is approximately 15-25 %, although the prevalence varies among different populations and depends on age, sex and the health of the oral and transcutaneous needle aspiration was carried out. Numerous mobile trophozoites of trichomonads were found by microscopy and culturing for trichomonas was performed. The species was finally characterized as Trichomonastenax by polymerase chain reaction and sequencing. Studies have shown that T. tenax can be found in humans in atypical locations such as the salivary glands and upper and lower respiratory tracts
Entamoeba gingivalis and Trichomonastenax in periodontal health and disease: a systematic review and meta-analysis Entamoeba gingivalis and Trichomonastenax in periodontal health and disease: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review
fluid (BALF). Finally, all positive specimens were subjected to DNA sequencing and phylogenetic analysis. Among 115 bronchoalveolar lavage fluid samples, ten samples tested positive in nested PCR (10/115), while no samples were positive in wet mount microscopy (0/115) (P < 0.01). Among the ten positive specimens, two were identified as Tetratrichomonas spp. and the other eight as Trichomonastenax
of case reports suggest, with Trichomonastenax being the most frequent. Surveys of neonates and infants suggest that aberrant Trichomonas vaginalis infections can be higher and more serious than suggested by the few case reports. The density and location of infection might be as important, if not more so, than species in determining pathogenicity. Molecular diagnostic methods including DNA sequencing
Empyema caused by trichomonas. Empyema is one of the potential complications of lower respiratory tract infections. Very rarely, in predisposed individuals, empyema can be caused by Trichomonas species, of which Trichomonastenax appears to be the most common cause. Here, we present a case of trichomonal empyema in a 56-year-old man and review the available literature of this rare occurrence.
with T vaginalis corroborated that extensive cytotoxicity was caused by pathogenic trichomonads in man. Only living parasites were cytotoxic, and no trichomonal toxic products were implicated in disruption of the cell monolayer cultures. A pathogenic bovine trichomonad, Tritrichomonas foetus KV-1, produced half as much cell damage as did T vaginalis. Trichomonastenax, a non-pathogenic member
Pulmonary eosinophilia due to Trichomonastenax. A 39 year old woman was admitted with fever and an exacerbation of asthma. The chest radiograph showed extensive bilateral lung infiltrates, but transtracheal needle aspiration did not reveal any infectious organisms. The bronchoalveolar fluid lavage contained a large number of Trichomonastenax and an increased percentage of eosinophils
with trichomoniasis DIBA proved to be ineffective. The sensitivity of the assay with corpuscular antigen of T vaginalis was 1 x 10(4) cells/ml, with soluble antigen 47 micrograms/ml. Specificity of the assay was confirmed by lack of any cross-reactivity with Trichomonastenax. Tritrichomonas mobilensis and Candida albicans.
Two Unusual Occurrences of Trichomoniasis: Rapid Species Identification by PCR PCR analysis in two unusual occurrences of trichomoniasis, trichomonal empyema due to Trichomonastenax and Trichomonas vaginalis in an infant urine sample, allowed us to obtain rapid and accurate trichomonad species identification. The weak sensitivity of wet preparations and the low viability of the flagellates can
Specific clones of Trichomonastenax are associated with periodontitis. Trichomonastenax, an anaerobic protist difficult to cultivate with an unreliable molecular identification, has been suspected of involvement in periodontitis, a multifactorial inflammatory dental disease affecting the soft tissue and bone of periodontium. A cohort of 106 periodontitis patients classified by stages in patients of Trichomonastenax and the severity of the disease. Genotyping demonstrates the presence of strain diversity with three major different clusters and a relation between disease strains and the periodontitis severity (p<0.05). More frequently detected in periodontal cases, T. tenax is likely to be related to the onset or/and evolution of periodontal diseases.
Clinical Study of the Presence of TrichomonasTenax and Entamoeba Gingivalis in Patients With Periodontitis Clinical Study of the Presence of TrichomonasTenax and Entamoeba Gingivalis in Patients With Periodontitis - Full Text View - ClinicalTrials.gov Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort. Hide glossary GlossaryStudy record managers: refer WarningYou have reached the maximum number of saved studies (100).Please remove one or more studies before adding more. Clinical Study of the Presence of TrichomonasTenax and Entamoeba Gingivalis in Patients With Periodontitis (Paro-Proto 2) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated